Abstract:OBJECTIVE:To evaluate the feasibility of the chitosan-poly (lactide-co-glycolide) (PLGA) double-walled microspheres for sustained release of bioactive nerve growth factor (NGF) in vitro. METHODS:NGF loaded chitosan-PLGA double-walled microspheres were prepared by emulsion-ionic method with sodium tripolyphosphate (TPP) as an ionic cross-linker. The double-walled microspheres were cross-linked by different concentrations of TPP [1%, 3%, 10% ( W/ V)]. NGF loaded PLGA microspheres were also prepared. The outer and inner structures of double-walled microspheres were observed by light microscopy, scanning electron microscopy, confocal laser scanning microscopy, respectively. The size and distribution of microspheres and fourier transform infra red spectroscopy (FT-IR) were analyzed. PLGA microspheres with NGF or chitosan-PLGA double-walled microspheres cross-linked by 1%, 3%, and 10%TPP concentration (set as groups A, B, C, and D respectively) were used to determine the degradation ratio of microspheres in vitro and the sustained release ratio of NGF in microspheres at different time points. The bioactivity of NGF (expressed as the percentage of PC12 cells with positive axonal elongation reaction) in the sustained release solution of chitosan-PLGA double-walled microspheres without NGF (set as group A1) was compared in groups B, C, and D. RESULTS:The chitosan-PLGA double-walled microspheres showed relative rough and spherical surfaces without aggregation. Confocal laser scanning microscopy showed PLGA microspheres were evenly uniformly distributed in the chitosan-PLGA double-walled microspheres. The particle size of microspheres ranged from 18.5 to 42.7 μm. The results of FT-IR analysis showed ionic interaction between amino groups and phosphoric groups of chitosan in double-walled microspheres and TPP. In vitro degradation ratio analysis showed that the degradation ratio of double-walled microspheres in groups B, C, and D appeared faster in contrast to that in group A. In addition, the degradation ratio of double-walled microsphere in groups B, C, and D decreased when the TPP concentration increased. There were significant differences in the degradation ratio of each group ( P<0.05). In vitro sustained release ratio of NGF showed that when compared with PLGA microspheres in group A, double-walled microspheres in groups B, C, and D released NGF at a relatively slow rate, and the sustained release ratio decreased with the increase of TPP concentration. Except for 84 days, there was significant difference in the sustained release ratio of NGF between groups B, C, and D ( P<0.05). The bioactivity of NGF results showed that the percentage of PC12 cells with positive axonal elongation reaction in groups B, C, and D was significantly higher than that in group A1 ( P<0.05). At 7 and 28 days of culture, there was no significant difference between groups B, C, and D ( P>0.05); at 56 and 84 days of culture, the percentage of PC12 cells with positive axonal elongation reaction in groups C and D was significantly higher than that in group B ( P<0.05), and there was no significant difference between groups C and D ( P>0.05). CONCLUSION:NGF loaded chitosan-PLGA double-walled microspheres have a potential clinical application in peripheral nerve regeneration after injury.

Thermoresponsive and Biodegradable Hydrogels for Sustained Release of Nerve Growth Factor to Stimulate Neurite Outgrowth

Laminin-modified Gellan Gum Hydrogels Loaded with the Nerve Growth Factor to Enhance the Proliferation and Differentiation of Neuronal Stem Cells

Sustainable Release of Nerve Growth Factor for Peripheral Nerve Regeneration Using Nerve Conduits Laden with Bioconjugated Hyaluronic Acid-Chitosan Hydrogel

Integration Of Phase-Change Materials With Electrospun Fibers For Promoting Neurite Outgrowth Under Controlled Release

A Novel Nerve Guidance Conduit with Sustained Release of NGF Enhances Sciatic Nerve Regeneration

Injectable Glycosaminoglycan-Based Cryogels from Well-Defined Microscale Templates for Local Growth Factor Delivery

Bioactive Self-Assembling Peptide Hydrogels Functionalized with Brain-Derived Neurotrophic Factor and Nerve Growth Factor Mimicking Peptides Synergistically Promote Peripheral Nerve Regeneration

Nerve-repair Conduit Formed of Polymeric Tissue-Engineering Fibers Sustained-Releasing Nerve Growth Factor of Native Form

Photothermal Responsive Cell-Laden PNIPAM Self-Rolling Hydrogel Containing Dopamine Enhanced MWCNTs for Peripheral Nerve Regeneration

Facilitate Angiogenesis and Neurogenesis by Growth Factors Integrated Decellularized Matrix Hydrogel

Preparation and evaluation of an injectable chitosan-hyaluronic acid hydrogel for peripheral nerve regeneration

Integrating Graphene Oxide-Hydrogels and Electrical Stimulation for Controlled Neurotrophic Factor Encapsulation: A Promising Approach for Efficient Nerve Tissue Regeneration

Nanoparticle Mediated Controlled Delivery of Dual Growth Factors

A Shape-Persistent Plasticine-Like Conductive Hydrogel with Self-Healing Properties for Peripheral Nerve Regeneration

Injectable, Antioxidative, And Neurotrophic Factor-Deliverable Hydrogel For Peripheral Nerve Regeneration And Neuropathic Pain Relief

Controlled Release of Recombinant Human Nerve Growth Factor (rhngf) from Poly[(lactic Acid)‐co‐(glycolic Acid)] Microspheres for the Treatment of Neurodegenerative Disorders

[The fabrication and related properties study of chitosan-poly (lactide-co-glycolide) double-walled microspheres loaded with nerve growth factor].

A Neurotrophic Peptide-Functionalized Self-Assembling Peptide Nanofiber Hydrogel Enhances Rat Sciatic Nerve Regeneration

Fibrous polypeptide based bioscaffold delivery of minocycline hydrochloride for nerve regeneration

Incorporation and Release of Dual Growth Factors for Nerve Tissue Engineering Using Nanofibrous Bicomponent Scaffolds

Using NGF heparin-poloxamer thermosensitive hydrogels to enhance the nerve regeneration for spinal cord injury